Why exactly is MRD testing important for myeloma patients, and what do the numbers mean? Read Cherie Rineker's latest blog to learn what she discovered.

Read Blog

Is there a way to return to normal after diagnosis with an incurable disease? Read Beth Kart Probert's latest blog to learn how she overcame her own fears.

Read Blog

What is it like to face a cancer for a second time? Read Andrew Schorr's latest blog to learn his experience when he needed re-treatment for his CLL after 17 years.

Read Blog

Myeloma patient Cherie Rineker described herself as "dying to get into a trial" before she joined a CAR T-cell therapy clinical trial. Read her latest blog with the third part about her cancer journey.

Read Blog

Myeloma patient Cherie Rineker described herself as "dying to get into a trial" before she joined a CAR T-cell therapy clinical trial. Read her latest blog with the second part about her cancer journey.

Read Blog

Myeloma patient Cherie Rineker described herself as "dying to get into a trial" before she joined a CAR T-cell therapy clinical trial. Read her latest blog to learn about her cancer journey.

Read Blog

Just back from the Biden Cancer Summit in Washington, DC, Andrew Schorr shares his personal reflections as a two-time cancer survivor. Read his blog for his summary and obstacles to overcome in cancer care.

Read Blog

Can exercise during cancer treatment really make a difference in recovery? Read Cathy Skinner's blog to learn what key research shows.

Read Blog

Does fatigue plus lethargy equal relapse? Read Jeff Folloder's latest blog about his CLL testing and questions from his doctor to learn what he discovered.

Read Blog

How should you feel when your CLL tests come back as practically perfect? Read Larry Saltzman's latest blog for his thoughts abut his tests and the six degrees of separation related to cancer.

Read Blog
December 2018
S M T W T F S
< Nov   Jan
  1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31  

Archive

more reset

Page last updated on March 7, 2017